| Financials | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Revenue (Cr) | 6,606.10 | 7,990.82 | 9,720.20 | 11,556.00 | 11,879.15 |
| Net Profit (Cr) | 703.10 | 679.42 | 419.08 | 789.93 | 871.58 |
| EPS | 90.99 | 87.90 | 55.17 | 102.35 | 111.44 |
| BVPS | 480.28 | 555.29 | 600.81 | 688.71 | 788.01 |
| ROE | 18.99 | 15.88 | 9.09 | 14.73 | 14.14 |
| Debt to Equity | 0.84 | 0.89 | 1.07 | 0.98 | 0.97 |
GlaxoSmithKline's consolidated financials show a similar pattern of growth. The revenue for March 2025 was Rs 974.37 Crore, up from Rs 949.42 Crore in December 2024. The net profit for the same period was Rs 262.87 Crore, compared to Rs 229.88 Crore in the previous quarter. The EPS also increased, reaching Rs 15.52 in March 2025.
Looking at the annual data, GlaxoSmithKline has demonstrated consistent growth in revenue and net profit. Revenue increased from Rs 2,925.60 Crore in 2021 to Rs 3,749.21 Crore in 2025. The net profit also rose significantly from Rs 287.27 Crore to Rs 927.58 Crore over the same period. Key financial ratios include a Book Value Per Share (BVPS) of Rs 115.19 and a Return on Equity (ROE) of 47.67% in March 2025.
| Financials | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Revenue (Cr) | 2,925.60 | 3,278.03 | 3,251.72 | 3,453.71 | 3,749.21 |
| Net Profit (Cr) | 287.27 | 380.77 | 607.64 | 589.96 | 927.58 |
| EPS | 31.35 | 99.29 | 36.08 | 41.14 | 54.52 |
| BVPS | 87.26 | 157.19 | 102.79 | 104.93 | 115.19 |
| ROE | 24.22 | 63.64 | 35.41 | 33.42 | 47.67 |
| Debt to Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Bharti Hexacom's standalone financials also reflect growth. For March 2025, the revenue was Rs 4,673 Crore, compared to Rs 4,618 Crore in December 2024. The net profit was Rs 534 Crore, while in the previous quarter it was Rs 383 Crore. The EPS stood at Rs 20.15 for March 2025.
Annually, Bharti Hexacom has increased its revenue from Rs 2,832 Crore in 2021 to Rs 4,934 Crore in 2025. The net profit has risen from Rs 340 Crore to Rs 729 Crore during the same period. Key financial ratios include a Book Value Per Share (BVPS) of Rs 1,261.62 and a Return on Equity (ROE) of 51.81% in March 2025.
| Financials | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Revenue (Cr) | 2,832 | 3,886 | 4,788 | 4,581 | 4,934 |
| Net Profit (Cr) | 340 | 536 | 571 | 569 | 729 |
| EPS | 305.35 | 481.03 | 512.15 | 510.31 | 653.71 |
| BVPS | 793.33 | 976.00 | 1,229.20 | 1,431.71 | 1,261.62 |
| ROE | 38.48 | 49.28 | 41.66 | 35.64 | 51.81 |
| Debt to Equity | 0.00 | 0.00 | 0.18 | 0.00 | 0.00 |
The presented data provides a snapshot of the financial health and recent market performance of key stocks within the NIFTY MIDCAP 150 index.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.